BRIEF-EMA advises on development plan for GSK Ebola vaccine

* Given scientific advice to GSK on its development plan for an Ebola vaccine
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.